Ginkgo Investor Conference Presentation Deck

"In our Q3 earnings call Ginkgo updated our 2021 outlook on the number of new cell programs, Foundry revenue, A and Biosecurity revenue - I'm happy to report that based on preliminary unaudited estimates for the full year, we expect to meet or beat all of those, with Biosecurity revenue exceeding our outlook by over 50%" *** Property of Ginkgo Bioworks - 4 J.P. MORGAN HEALTHCARE CONFERENCE 2022

View entire presentation